Výsledky vyhledávání - "Marian OLTMAN"

Akademický článek

Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals

Autor: Sylvia Drazilova, Martin Janicko, Lubomir Skladany, Pavol Kristian, Marian Oltman, Maria Szantova, Dusan Krkoska, Eva Mazuchova, Lubica Piesecka, Veronika Vahalova, Marek Rac, Ivan Schreter, Ladislav Virag, Tomas Koller, Adriana Liptakova, Miriam Ondrasova, Peter Jarcuska

Publikováno v: Canadian Journal of Gastroenterology and Hepatology, Vol 2018 (2018)

Background and Aims. Chronic hepatitis C is a systemic disease and type 2 diabetes mellitus (T2DM) belongs to more common extrahepatic. The aim of this study was to (i) explore the prevalence of impaired fasting glucose (IFG) and T2DM in patients wit

Externí odkaz: https://doaj.org/article/df33a1c69b4f4e7892e384221b2e50f3

Zobrazit plný text záznamu

Questionnaire for risk factors of alcoholic and nonalcoholic fatty liver disease

Autor: Maria SZANTOVA, Lubomir SKLADANY, Martin JANICKO, Marian OLTMAN, Sylvia DRAZILOVA, Maria BELOVICOVA, Martin ZIMA, Viera KUPCOVA, Svetlana ADAMCOVA-SELCANOVA, Tomas KOLLER, Marek RAC, Martina JAKABOVICOVA, Tereza HLAVATA, Xenia FAKTOROVA, Zuzana DURKOVICOVA, Monika SZAMOSOVA, Peter JARCUSKA, Viliam MOJTO, Maria VORLICKOVA

Publikováno v: Bratislavske lekarske listy. 123(7)

Non-communicable diseases are estimated to account for 90 % of total deaths and 19 % of premature deaths in Slovakia. Major preventable risk factors of premature mortality are overweight, obesity and alcohol consumption.Screening of risk factors rela

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec8e25becf01d07be003072b3e6e47b2
https://pubmed.ncbi.nlm.nih.gov/35907056

Zobrazit plný text záznamu

Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study

Autor: Wolfgang Vogel, M. Blachier, Lelia Thornton, Wim Laleman, Ieva Tolmane, Antonio Craxì, Mojca Matičič, Hans Van Vlierberghe, Christoph Sarrazin, Laura Harcouet, Joël Mossong, Ilias Gountas, Matthew E. Cramp, Devin Razavi-Shearer, Soo Aleman, Lyudmila Mateva, Ann-Sofi Duberg, Vratislav Nemecek, Jordan Genov, Michael Manns, Anne Øvrehus, Irena Hrstić, Kimberly Murphy, Stefano Vella, Krzysztof Tomasiewicz, Francesco Negro, Nina Weis, Antonio Javier Blasco, Agita Jeruma, Karolin Falconer, Danute Speiciene, Jonas Valantinas, Jose Luis Calleja, Jan Sperl, Gabor Horvath, Filipe Calinas, Peter Jarcuska, Jerneja Videčnik-Zorman, Ivan Schréter, Kathryn Razavi-Shearer, Christophe Moreno, Sergeja Gregorčič, Angelos Hatzakis, Pierre Van Damme, Riina Salupere, Massimo Colombo, Robert J. de Knegt, Peter J Smit, Dijana Nonkovic, Daniela K van Santen, Waldemar Halota, Rui Sarmento-Castro, Jean-Michel Delile, Suzanne Norris, Vana Sypsa, Robert Flisiak, Carole Seguin-Devaux, Martin Lagging, Liana Gheorghe, Mihály Makara, Javier García-Samaniego, Christophe Hézode, Jennifer Kieran, Marian Oltman, Peter Stärkel, Victor de Ledinghen, Pablo Lázaro, Stefan Zeuzem, E. A. Croes, Patrick Hoffmann, Matti Maimets, Francesco Saverio Mennini, Kostas Athanasakis, Chris Estes, Stephen D. Ryder, Sarah Robbins, Françoise Roudot-Thoraval, Martin Kåberg, Kaarlo Simojoki, Sona Frankova, Adrian Goldis, Marietta Simonova, Kyriakos Souliotis, Ken Pasini, Homie Razavi, Rui Tato Marinho, Sarah Blach, Pavol Kristian, Rumiana Mitova, Loreta A. Kondili, Maria Buti, Helen Nde, Boris Lukšić, Henrik Krarup, Dominique Vandijck, Henk W. Reesink, David A. M. C. van de Vijver, Iskren Kotzev, Jessie Gunter, Adriaan J. van der Meer, Martti Färkkilä, Baiba Rozentale, Perttu Arkkila, Krasimir Antonov, Jan Gerstoft, Béla Hunyady, Peer Brehm Christensen, Ivane Gamkrelidze, Valentina Liakina, Michael Gschwantler, Deian Jelev, Tatjana Reic, George V. Papatheodoridis, Jonathan Schmelzer, Daniel Struck

Publikováno v: Krarup, H & European Union HCV Collaborators 2017, ' Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030 : a modelling study ', The Lancet Gastroenterology & Hepatology, vol. 2, no. 5, pp. 325-336 . https://doi.org/10.1016/S2468-1253(17)30045-6
Lancet Gastroenterology & Hepatology, 2(5), 325-336. Elsevier Ltd.
The Lancet Gastroenterology & Hepatology, Vol. 2, No 5 (2017) pp. 325-336
Lancet gastroenterology & hepatology
The lancet. Gastroenterology & hepatology, 2(5), 325-336. HANLEY & BELFUS-ELSEVIER INC
Øvrehus, A L H & European Union HCV Collaborators 2017, ' Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030 : a modelling study ', The Lancet Gastroenterology & Hepatology, vol. 2, no. 5, pp. 325-336 . https://doi.org/10.1016/S2468-1253(17)30045-6

Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality worldwide. In the European Union (EU), treatment and cure of HCV with direct-acting antiviral therapies began in 2014. WHO targets are to achieve a 65% red

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6167fe45cfcadfaa8e9dc89df3a54984
https://doi.org/10.1016/s2468-1253(17)30045-6

Zobrazit plný text záznamu

New therapeutic options for HCV in Central Europe

Autor: Robert Flisiak, Martin Janicko, Mihály Makara, László Rókusz, Marian Oltman, Petr Urbánek

Publikováno v: Clinical and Experimental Hepatology

New therapeutic options became available in 2015 in the European Union. We present the availability of interferon-free regimens with direct acting antivirals (DAA) in four Central European countries – the Czech Republic, Hungary, Poland and Slovaki

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d8eb784c14b2f5414a7552407e0fcdf
https://doi.org/10.5114/ceh.2016.58850

Zobrazit plný text záznamu

Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals

Autor: Maria Szantova, Eva Mazuchova, Tomas Koller, Martin Janicko, Marian Oltman, Marek Rac, Veronika Vahalova, Lubomir Skladany, Adriana Liptakova, Miriam Ondrasova, Peter Jarcuska, Lubica Piesecka, Pavol Kristian, Ladislav Virág, Dusan Krkoska, Sylvia Drazilova, Ivan Schréter

Publikováno v: Canadian Journal of Gastroenterology & Hepatology
Canadian Journal of Gastroenterology and Hepatology, Vol 2018 (2018)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae6ac59c0178f8da143de4b9a329482e

Zobrazit plný text záznamu

Global prevalence and genotype distribution of hepatitis C virus infection in 2015:a modelling study

Autor: Hans Van Vlierberghe, Soo Aleman, Naveed Z. Janjua, Henry Lik-Yuen Chan, Olufunmilayo A. Lesi, Irena Hrstić, Abdullah M. Assiri, William Rosenberg, Moon sing Lai, Vladimir Chulanov, Jan Sperl, Beat Müllhaupt, Michael Manns, William Sievert, Sabahattin Kaymakoglu, Cesar Yaghi, Evy Yunihastuti, Pierre Van Damme, Jon G. Jonasson, Antonio Javier Blasco, Young Sik Kim, S. Olafsson, Rohani Jahis, Christoph Sarrazin, Manik Sharma, Aasim Yusuf, Omer Hajelssedig, Javier García-Samaniego, Boris Lukšić, Peter Stärkel, Stefan Zeuzem, Stephen Oguche, E. A. Croes, Abdullah S. Alghamdi, Richard Njouom, CE Omuemu, Carlos E Brandão Mello, Adam Mahomed, Behzad Hajarizadeh, Ogu Omede, Said A. Al-Busafi, Sarah Robbins, Peer Brehm Christensen, Ammal M. Metwally, Béla Hunyady, Gamal Esmat, Ivane Gamkrelidze, Maheeba Abdulla, Suzanne Norris, Sarah Blach, Harald Hofer, Maria C Mendes Correa, Devin Razavi-Shearer, Matti Maimets, Chien-Jen Chen, Peter Jarcuska, Marian Oltman, Francesco Negro, Ilias Gountas, Ayman Yosry, Sona Frankova, Adrian Goldis, Laurentius A. Lesmana, Ivan Schréter, Danute Speiciene, Kevork M. Peltekian, Berhane Redae, Stuart K. Roberts, Valentina Liakina, Seyed M Alavian, Wai-cheung C Lao, Ziv Ben-Ari, Imad Al Ghazzawi, Cheryl Brunton, Rudolf E. Stauber, Akram Khan, Tung-Hung Su, Manal H El-Sayed, Kimberly Murphy, Kyriakos Souliotis, Adriana Vince, Ramazan Idilman, Christophe Moreno, Angelos Hatzakis, Lewis R. Roberts, Richard Phillips, Jason Grebely, Michael Gschwantler, Hugo Cheinquer, Vana Sypsa, Samir Shah, Wolfgang Vogel, M. Blachier, Abate Bane, Henri Leleu, Saeed Hamid, Ohene Opare-Sem, Hamad Al-Romaihi, Wan-Long Chuang, Alexander J. Thompson, Agita Jeruma, Robert Flisiak, Catherine A.M. Stedman, Ingo van Thiel, Carole Seguin-Devaux, Jonathan Schmelzer, Juan F.Sanchez Avila, Rui Tato Marinho, Muhammad S. Memon, Nina Weis, Rosmawati Mohamed, Florian Bihl, Moon Seok Choi, David Kershenobich, Vic Arendt, Yee Tak Hui, Mei Hsuan Lee, N. N. Pimenov, Saad Al Kaabi, Ken Pasini, Henrik Krarup, Stefan Mauss, Shahin Merat, Khalid Al Namaani, Rong-Nan Chien, Perttu Arkkila, Henk W. Reesink, Françoise Roudot-Thoraval, Paul Marotta, Shirley Owusu-Ofori, Fadi H. Mourad, Abdul Rahman Bizri, Chris Estes, Heiner Wedemeyer, Faisal M. Sanai, Mihály Makara, Stephen D. Ryder, Mel Krajden, Laura Cisneros, Adriaan J. van der Meer, Eli Zuckerman, Matthew E. Cramp, Rui Sarmento-Castro, Magnus Gottfredsson, Gregory J. Dore, Huma Qureshi, Yasser Kamel, Olga Sagalova, Rifaat Safadi, Wim Laleman, Solomon Obekpa, Karolin Falconer, Edward Gane, Philip Bruggmann, Fernando Bessone, Jia-Horng Kao, Daniel Lavanchy, Riina Salupere, Anne Øvrehus, Ulus Salih Akarca, Monique Andersson, Man-Fung Yuen, Ala I. Sharara, Olav Dalgard, Homie Razavi, Gamal Shiha, Paulo R. Ferreira, George V. Papatheodoridis, Anatoly Shevaldin, Jawad Khamis, Waseem Hamoudi, Kathryn Razavi-Shearer, Vincent Ws Wong, Loreta A. Kondili, Maria Lucia Gomes Ferraz, Wasim Jafri, Pablo Lázaro, Faisal Abaalkhail, David H. Muljono, Youssif Al Serkal, Imam Waked, Zaher Koutoubi, Oidov Baatarkhuu, Nahum Méndez-Sánchez, Abraham O. Malu, Daniel Struck, Helen Nde, Alnoor Ramji, Ahmed Abdou, Antoine Abou Rached, Michael Li, Diana Nonković, Jorge Daruich, Ezequiel Ridruejo, Gül Ergör, Ann-Sofi Duberg, Krzysztof Tomasiewicz, Filipe Calinas, Hossein Poustchi, Layla Al-Dabal, Jessie Gunter, Mark W. Sonderup, Colm Bergin, Mario G. Pessoa, Jonas Valantinas, Asad Chaudhry, Junko Tanaka, Tsendsuren S. Oyunsuren, Soek Siam Tan, Vivek A. Saraswat, Young-Suk Lim, Ibrahim Altraif, Victor de Ledinghen, Faryal Al Lawati, Mette Rye Clausen, Ieva Tolmane, Antonio Craxì, Abdulrahman Aljumah, Elmoubashar Farag, Inka Aho, Sayed Himatt, Nishi Prabdial-Sing

Publikováno v: Christensen, P B, Øvrehus, A L H & The Polaris observatoriy HCV collaborators 2017, ' Global prevalence and genotype distribution of hepatitis C virus infection in 2015 : a modelling study ', The Lancet Gastroenterology & Hepatology, vol. 2, no. 3, pp. 161–176 . https://doi.org/10.1016/S2468-1253(16)30181-9
LANCET GASTROENTEROLOGY & HEPATOLOGY
The Lancet Gastroenterology & Hepatology, Vol. 2, No 3 (2017) pp. 161-176
Krarup, H & Polaris Observatory HCV Collaborators 2017, ' Global prevalence and genotype distribution of hepatitis C virus infection in 2015 : a modelling study ', The Lancet Gastroenterology & Hepatology, vol. 2, no. 3, pp. 161-176 . https://doi.org/10.1016/S2468-1253(16)30181-9

WOS: 000426979400014
PubMed ID: 28404132
Background The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate hepatitis C virus (HCV) infection by 2030, which can become a reality with the recent launch of direc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91fa1586aecb1dffed87aa24333582a6
https://portal.findresearcher.sdu.dk/da/publications/cdef7f82-202a-4bdc-9ca9-90196ff4240b

Zobrazit plný text záznamu

2972 Treatment of Chronic Hepatitis C With SOF/LDV Leads to a Significant Decrease of Fasting Glycaemia in Cirrhotic and IFG/T2DM Patients but Treatment With 3D Combo Only in IFG/T2DM Patients

Autor: Peter Jarcuska, Marian Oltman, Pavol Kristian, Lubomir Skladany, Martin Janicko, Sylvia Drazilova

Publikováno v: American Journal of Gastroenterology. 114:S1614-S1614

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c31fabbbd7f67e8b5d9f5430b511dbec
https://doi.org/10.14309/01.ajg.0000601420.27307.0b

Zobrazit plný text záznamu

Efficacy and safety of peginterferon α-2a (40 KD) plus ribavirin in treatment-naive chronic hepatitis C patients in Central and Eastern Europe

Autor: Rehák, Andreas Tietz, Diethelm Messinger, Marian Oltman, Petr Urbánek, Petr Husa, Ljubomir Ivanovski

Publikováno v: European Journal of Gastroenterology & Hepatology. 23:1004-1010

OBJECTIVE Assess the safety and efficacy of 24 or 48 weeks of treatment with peginterferon α-2a (40 KD) plus ribavirin in treatment-naive patients with chronic hepatitis C. METHODS All patients in this open-label multinational study were assigned at

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8cf970b0542a01beaf29b3fc62194a9
https://doi.org/10.1097/meg.0b013e32834b326b

Zobrazit plný text záznamu

Epidemiology of Helicobacter pylori infection in the Slovak Republic

Autor: Martin Nagy, Jarolim Sutka, Marian Oltman, Barbora Zacharova, Kuzela L

Publikováno v: Hepato-gastroenterology. 59(115)

BACKGROUND/AIMS The prevalence of H. pylori differs significantly both between and within countries. In general infection correlates inversely to socioeconomic conditions. The aim of our study was to asses the prevalence and social determinants of H.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f23f3f15611c59dac1e9b00a462899f9
https://pubmed.ncbi.nlm.nih.gov/22020911

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání